StockData
Eledon Pharmaceuticals, Inc. logo

Eledon Pharmaceuticals, Inc. (ELDN) stock

ELDNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$1.98+0.01 (+0.51%)

Close on Nov 17, 2026Market cap $160.90MP/E –Yield –

Eledon Pharmaceuticals operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Eledon Pharmaceuticals's operating cash flow for the twelve months ending Jun 30, 2026 was -$73.86M. For fiscal 2025 it was -$62.34M. The highest annual figure on record is -$4.92M in fiscal 2016.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$62.34M–
FY2024Dec 31, 2024-$47.27M–
FY2023Dec 31, 2023-$39.53M–
FY2022Dec 31, 2022-$28.42M–
FY2021Dec 31, 2021-$28.91M–
FY2020Dec 31, 2020-$15.21M–
FY2019Dec 31, 2019-$13.86M–
FY2018Dec 31, 2018-$11.89M–
FY2017Dec 31, 2017-$14.94M–
FY2016Dec 31, 2016-$4.92M–
FY2015Dec 31, 2015-$41.24M–
FY2014Dec 31, 2014-$21.12M–
FY2013Dec 31, 2013-$15.48M–
FY2012Dec 31, 2012-$9.33M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$22.68M–
Q1 FY2026Mar 31, 2026-$22.61M–
Q4 FY2025Dec 31, 2025-$14.09M–
Q3 FY2025Sep 30, 2025-$14.48M–
Q2 FY2025Jun 30, 2025-$17.71M–
Q1 FY2025Mar 31, 2025-$16.06M–
Q4 FY2024Dec 31, 2024-$18.99M–
Q3 FY2024Sep 30, 2024-$11.77M–
Q2 FY2024Jun 30, 2024-$7.77M–
Q1 FY2024Mar 31, 2024-$8.74M–
Q4 FY2023Dec 31, 2023-$9.13M–
Q3 FY2023Sep 30, 2023-$12.25M–
Q2 FY2023Jun 30, 2023-$8.22M–
Q1 FY2023Mar 31, 2023-$9.92M–
Q4 FY2022Dec 31, 2022-$9.48M–
Q3 FY2022Sep 30, 2022-$4.57M–
Q2 FY2022Jun 30, 2022-$6.22M–
Q1 FY2022Mar 31, 2022-$8.16M–
Q4 FY2021Dec 31, 2021-$9.21M–
Q3 FY2021Sep 30, 2021-$7.09M–
Q2 FY2021Jun 30, 2021-$7.45M–
Q1 FY2021Mar 31, 2021-$5.17M–
Q4 FY2020Dec 31, 2020-$9.43M–
Q3 FY2020Sep 30, 2020-$561.00K–
Q2 FY2020Jun 30, 2020-$3.02M–
Q1 FY2020Mar 31, 2020-$2.20M–
Q4 FY2019Dec 31, 2019-$2.02M–
Q3 FY2019Sep 30, 2019-$2.89M–
Q2 FY2019Jun 30, 2019-$4.92M–
Q1 FY2019Mar 31, 2019-$4.02M–
Q4 FY2018Dec 31, 2018-$3.35M–
Q3 FY2018Sep 30, 2018-$2.94M–
Q2 FY2018Jun 30, 2018-$3.33M–
Q1 FY2018Mar 31, 2018-$2.27M–
Q4 FY2017Dec 31, 2017-$2.61M–
Q3 FY2017Sep 30, 2017-$3.42M–
Q2 FY2017Jun 30, 2017-$8.03M–
Q1 FY2017Mar 31, 2017-$882.00K–
Q4 FY2016Dec 31, 2016-$1.28M–
Q3 FY2016Sep 30, 2016-$1.48M–

More Eledon Pharmaceuticals figures

See a number that looks wrong?